Plavix

FDA approves generic Plavix (clopidogrel) in a major after heart attack decision

king on a chess board As predicted in The Essential Guide to Prescription Drugs, 12 Top Meds for 2012, the FDA today approved the first generic form of Plavix (clopidogrel).

Medicines and Your Family, Second Edition, Heart Attack Transition

Heart attacks, medicines, MI
$12.99

Easy to understand "What have I had, what do I need to do?" format that you don't need a PhD to understand. Find out about key risk factors and crucial medicines to help prevent a heart attack. Describes how heart problems evolve, what may have happened in the hospital and key questions to ask your doctor, nurse and pharmacist. Includes check lists you can bring to your doctor on questions to ask and crucial medicines to help prevent a return to the hospital. This edition tells Top Ten tips for you and your family to know about therapy and keeping your recovery on track.

$12.99

The Essential Guide to Prescription Drugs, A New Look at Plavix (clopidogrel)

EGPD on Plavix
$9.99

Will this medicine be going generic? Do the benefits outweigh the risks? Find out a wealth of important information in more than 40 categories. As usual, the Essential Guide helps you and your family with crucial herbal and prescription drug interactions, 12 important things to know if you take Plavix, tests to talk to your doctor about to follow up on treatment and even steps you can take to help get the most from this and other medicines. Includes where to find a free patient assistance program.

 

Comb-Bound Booklet.

$9.99

This website is not intended as medical advice, and you should consult your doctor before changing or adding any medicines or vitamins to those you may now be taking and about applying any strategies BEFORE you adopt any approach in this report. While diligent care has been taken to ensure the accuracy of the information provided during the preparation of this edition, no claim is made that all known actions, uses or side effects, strategies for cost containment, targets or cholesterol pathways are included in this report. The accuracy and currentness of information are ever subject to change relative to new guidelines, new information derived from drug research, development and general usage.